Page 33 - Crispr News Today

The potential of CRISPR-based diagnostic assays and treatment approaches against COVID-19 In their review paper recently published in the Indian Journal of Clinical Biochemistry, a group of authors discusses currently available and forthcoming CRISPR-based diagnostic assays, as well as the possibility of using the CRISPR/Cas system as a salient treatment or prevention strategy in the fight against coronavirus disease 2019 (COVID-19). The unfaltering COVID-19 pandemic is caused by the severe ac...

CRISPR/Cas technology helped revolutionize diagnostics and gene therapy Announcing a new article publication for BIO Integration journal. In this mini review article the authors Meiyu Qiu and Pei Li from Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea summarize CRISPR/Cas-based Diagnostics and Gene Therapy. Clustered regularly interspaced short palindromic repeats (CRISPR) technology, an easy, rapid, cost-effective, and precise gene-editing technique, has...

Making Excellence a Habit: The Secret to Building a World-Class Healthcare System in India By Dr. V Mohan, Penguin Random House One of India’s leading diabetologists, Dr V Mohan writes in his memoir about the fundamentals that according to him, make a person achieve meaningful success and conquer fear about failure. He lists hard work, passion for what you do, and focus as a winners secrets, among other qualities. The book is a handy guide to success based on his personal anecdotes about per...

Date Time Researchers call for greater awareness of unintended consequences of CRISPR gene editing CRISPR-Cas9 genome editing can lead to unintended mutations at the targeted section of DNA in early human embryos, researchers have revealed. This highlights the need for further research into the effects of CRISPR-Cas9 genome editing, especially when used to edit human DNA in laboratory research. We and others are trying to develop and refine the tools to assess these complex mutations. ...

April 12, 2021 -- A new gene silencing tool allows scientists to switch genes on and off without altering genetic sequences. The tool, described in a paper published in Cell on April 9, uses a modified CRISPR-Cas9 system to introduce reversible epigenetic changes that control gene expression. The classic CRISPR-Cas9 system led to an explosion in gene editing studies since it was first developed almost a decade ago. It became quickly popular thanks to its ease of use compared to previous gene e...

Apr 5, 2021 3:30pm Inscripta’s latest funding round will support the development and distribution of its Onyx benchtop platform, which uses CRISPR gene editing technology for fully automated genomic engineering. (AstraZeneca) Inscripta just got another step closer to achieving its mission of bringing CRISPR gene editing technology to the scientific masses. The genomic engineering company, a member of Fierce Medtech’s 2019 Fierce 15, recently closed a series E funding round totaling ...

Walter Isaacson and Ezra Klein discuss the implications of humanity’s awesome, terrifying takeover of evolution.

The Best Of Our Knowledge #1593 There’s a whole lot going on inside our head that we don’t understand. Don’t feel bad, there are a lot of world class experts that are just as puzzled about what makes the human brain tick. Bret Stetka tries to unravel what we actually do know in his new book called “ A History of the Human Brain – From the Sea Sponge to CRISPR, How Our Brain Evolved”. Bret Stetka is editorial director at Medscape, the professional division of Web MD. He is also a con...

Mar 15 2021 Read 334 Times G+FLAS Life Sciences, has been granted a non-exclusive license agreement to access to ERS Genomics’ CRISPR/Cas9 patent portfolio. The Korean biotech (Seoul) produces research tools and reagents under ISO 13485 and ISO 9001 and is applying CRISPR PLUS technology to the development of drugs and production of CRISPR genome edited plants in a non-GMO way. ERS Genomics holds an exclusive worldwide license from co-founder and recent Nobel prize winner Dr. Emmanuelle Charp...

Featuring major new developments in cancer and immunology research, from cutting-edge technologies to novel techniques and top resources to advance your work, the free-to-attend Virtual Summit will offer an interactive forum for scientists and scientific manufacturers to connect and share knowledge and solutions at this critical time.  Register free now to access expert presentations by leading scientists and technology providers, live Q&As, virtual resource hubs, new product launches, networ...